Lifeboat Foundation

Great interview with Villanova University astronomer Ed Guinan, who explains today’s news of the latest paper on why Betelgeuse experienced such a deep dimming this past Fall and Winter. We cover a lot of territory from how Gene Roddenberry chose the name Guinan for the Whoopi Goldberg character on Star Trek’s Next Generation to the history behind the pole star’s mysterious brightening; to the Dog Star Sirius; to why life might still be possible around red dwarfs; to our Sun’s longterm future. Please listen!

In a stroke of serendipity during a wide-ranging podcast interview, Villanova University astronomer Edward Guinan explains the paper behind today’s news flap about the red supergiant star’s inexplicable dimming. The most recent explanation is that dust generated from cooling plasma spewed forth from the massive star’s interior caused Betelgeuse to appear more dim than usual. While Guinan acknowledges this scenario is a possibility, he remains skeptical. Please listen to this candid and entertaining episode!

Continue reading “Episode 11 --- Betelgeuse Dimming Mystery Might Be Solved, Says Edward Guinan” »

Safe Messaging

Cybersecurity experts have long warned that quantum computers, whenever it is that they become useful, will render useless most conventional forms of encryption. This new satellite experiment, which is described in research published in the journal Nature, suggests that it may be possible to send secure messages yet.

“A remarkable feature of the entanglement-based quantum cryptography as we demonstrated here is that such security is ensured even if the satellite is controlled by an adversary,” University of Science and Technology physicist Jian-Wei Pan told Space.com.

A team of researchers from Heriot-Watt University, the Indian Institute of Technology and the University of Glasgow has demonstrated a way to transport entangled particles through a commercial fiber cable with 84.4% fidelity. In their paper published in the journal Nature Physics, the group describes using a unique attribute of entanglement to achieve such high fidelity. Andrew Forbes and Isaac Nape with the University of Witwatersrand have published a News & Views piece in the same journal issue outlining issues with sending entangled particles across fiber cables and the work done by the team in this new effort.

The study of entanglement, its properties and possible uses has made headlines due to its novelty and possible applications —particularly in quantum computers. One of the roadblocks standing in the way of its use as an international computer communications medium is noise encountered along the path through fiber cables that destroys the information they carry. In this new effort, the researchers have found a possible solution to the problem—using a unique attribute of entanglement to reduce losses due to noise.

The work exploited a property of quantum physics that allows for mapping the medium (fiber cable) onto the quantum state of a particle moving through it. In essence, the entangled state of a particle (or photon in this context) created an image of the fiber cable, which allowed for reversing the scattering within it as a photon was transmitted. And furthermore, the descrambling could be achieved without having anything touch either the fiber or the photon that moved through it. More specifically, the researchers sent one of a pair of photons through a complex medium, but not the other. Both were then directed toward spatial light modulators and then on to detectors, and then finally to a device used to correlate coincidence counting. In their setup, light from the photon that did not pass through the complex medium propagated backward from the detector, allowing the photon to appear as if it had emerged from the crystal as the other photon.

The US Food and Drug Administration (FDA) has approved viltolarsen (Viltepso; NS Pharma) for the treatment of patients with Duchenne muscular dystrophy amenable to exon 53 skipping, making it only the second FDA-approved therapy for this specific DMD gene mutation.

The agent from NS Pharma, delivered via weekly intravenous infusion, was granted accelerated approval via its priority review, fast track, orphan drug, and rare disease designations after its new drug application was accepted earlier this year. In March, NS Pharma launched an expanded access program for qualified patients.

The approval was granted based on findings from a phase 2 clinical trial (NCT02740972) and long-term extension study, details of which were recently published in JAMA Neurology. Among 16 participants age 4 to 9, significant drug-induced dystrophin production was observed in both viltolarsen dose cohorts (40 mg/kg per week: mean, 5.7% [range, 3.2–10.3] of normal; 80 mg/kg per week: mean, 5.9% [range, 1.1–14.4] of normal), with 15 (94%) patients achieving dystrophin levels greater than 2% of normal and 14 of 16 (88%) achieving levels greater than 3% of normal.

A cable cut a large gash into the radio telescope this week and it’s uncertain when it will be back in working order.

Aguas Zarcas, a space rock that crashed last year in a Costa Rican rainforest, has captivated researchers and collectors.

This new 4k footage from Mars taken by the Curiosity Rover will leave you in complete awe of ‘The Red Planet’.

This video explains the details of eukaryotes, replication in eukaryotes and differences between prokaryotic DNA replication and eukaryotic DNA replication.

After recalling more than 100 hand sanitizers that contain methanol, the FDA introduces a new toxin (1-propanol) that can depress the central nervous system if wrongfully ingested.